Nonalcoholic Steatohepatitis Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Published By: Syndicate <strong>Market</strong> Research<br />
<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong> - Global<br />
Industry Perspective, Comprehensive<br />
Analysis and Forecast, 2014 – 2020<br />
Joel John<br />
3422 SW 15 Street, Suit #8138,<br />
Deerfield Beach,<br />
Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Toll Free: 1-855-465-4651<br />
sales@Syndicate<strong>Market</strong>Research.com<br />
http://www.syndicatemarketresearch.com/
<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong><br />
<strong>Nonalcoholic</strong> steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the<br />
liver. It is also known as silent liver disease. It is a type of nonalcoholic fatty liver disease (NAFLD), which<br />
mainly affects people with diabetes and obesity. <strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> (NASH) is defined by<br />
histological hallmarks of inflammation, hepatic steatosis, cell death, and fibrosis. A number of drugs<br />
used to treat medical situation have been NASH, such as amiodarone (Corderone, Pacerone), tamoxifen<br />
(Nolvadex), perhexiline maleate (Pexhid) and steroids (eg, prednisone). Medical studies have identified a<br />
strong connection of NASH with certain risk factors such as insulin resistance, oxidative stress and<br />
release of toxic inflammatory proteins.<br />
<strong>Nonalcoholic</strong> steatohepatitis is a gradually becoming common chronic liver disease around the world and<br />
is closely related with diabetes and obesity. Rising incidence of NAFLD cases, changing lifestyle<br />
patterns, increasing rate of obesity and diabetes, and initiatives for research and development are the<br />
major driving factors of this market. However, insufficient information about the pathophysiology of NASH<br />
tissue and ineffective diagnostic technology for NASH is considered to restraint in this market.<br />
Browse the full “<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong> - Global Industry Perspective,<br />
Comprehensive Analysis and Forecast, 2014 – 2020" report at<br />
http://www.syndicatemarketresearch.com/market-analysis/nonalcoholic-steatohepatitismarket.html<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong><br />
The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and<br />
an analysis of Porter’s five forces model for the nonalcoholic steatohepatitis market has also been<br />
included. It includes company market share analysis, product portfolio of the major industry participants.<br />
The report provides detailed segmentation of the nonalcoholic steatohepatitis market based on drugs<br />
type and region segment. GFT505, Obeticholic Acid (INT-747), Simtuzumab and Liraglutide (Victoza),<br />
Vitamin E, Poglitazone, Placebo is the drug type segment of nonalcoholic steatohepatitis market.<br />
Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin<br />
America, and Middle East and Africa with its further bifurcation into major countries including U.S.,<br />
Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for<br />
nonalcoholic steatohepatitis based on individual products and applications in all the regions and<br />
countries. The nonalcoholic steatohepatitis market is dominated by North America followed by Asia<br />
Pacific. Asia pacific is expected to the fastest growing segment in the forecast period.<br />
Get sample research report at http://www.syndicatemarketresearch.com/request-forsample.html?flag=S&repid=52719<br />
The report covers detailed competitive outlook including company profiles of the key participants<br />
operating in the global market. Key players profiled in the report include Intercepts Pharmaceuticals,<br />
Exalenz Bioscience Inc., Galectin Therapeutics Inc., Genfit, Gilead Science, AstraZeneca plc,<br />
Echosense SA, Raptor Pharmaceutical Corp, Matinas Biopharma Holdings Inc., Enzo Biochem, Inc.,<br />
Galmed Pharmaceuticals Ltd., Perspectum Diagnostics and Novo Nordisk.<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong><br />
This report segments the global nonalcoholic steatohepatitis market as follows:<br />
Global <strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong>: Drug Type Segment Analysis<br />
<br />
<br />
<br />
<br />
<br />
<br />
GFT505<br />
Obeticholic Acid (INT-747)<br />
Simtuzumab and Liraglutide (Victoza)<br />
Vitamin E<br />
Poglitazone<br />
Placebo<br />
Global <strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong>: Regional Segment Analysis<br />
<br />
<br />
<br />
North America<br />
o U.S.<br />
Europe<br />
o UK<br />
o France<br />
o Germany<br />
Asia Pacific<br />
o China<br />
o Japan<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong><br />
<br />
<br />
o India<br />
Latin America<br />
o Brazil<br />
Middle East And Africa<br />
Browse the full “<strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong> <strong>Market</strong> - Global Industry Perspective,<br />
Comprehensive Analysis and Forecast, 2014 – 2020" report at<br />
http://www.syndicatemarketresearch.com/market-analysis/nonalcoholic-steatohepatitismarket.html<br />
Syndicate market research<br />
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
FREE)<br />
Email: sales@Syndicate<strong>Market</strong>Research.com<br />
Tel: +1-855-465-4651 (US/CAN TOLL<br />
Web:http://www.syndicatemarketresearch.com/<br />
sales@Syndicate<strong>Market</strong>Research.com
Change language